Nalaganje...
Phase I dose-escalating trial of Escherichia coli purine nucleoside phosphorylase and fludarabine gene therapy for advanced solid tumors(†)
BACKGROUND: The use of Escherichia coli purine nucleoside phosphorylase (PNP) to activate fludarabine has demonstrated safety and antitumor activity during preclinical analysis and has been approved for clinical investigation. PATIENTS AND METHODS: A first-in-human phase I clinical trial (NCT 013101...
Shranjeno v:
| izdano v: | Ann Oncol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Oxford University Press
2015
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4560028/ https://ncbi.nlm.nih.gov/pubmed/25899782 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdv196 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|